Sildenafil Tablet, Film Coated
Product Images NDC 31722-965

12 FDA label images from Camber Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 31722-965). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafiltabletsstructure (Sildenafiltabletsstructure)

Sildenafiltabletsstructure (Sildenafiltabletsstructure)
Chemical structure diagram of the active ingredient Sildenafil, showing its molecular components and the chemical bonds connecting them.*
FDA Label Image

Sildenafiltabletsfigture1 (Sildenafiltabletsfigture1)

Sildenafiltabletsfigture1 (Sildenafiltabletsfigture1)
A line graph showing systolic blood pressure changes over 24 hours post-dose comparing Sildenafil 100 mg to a placebo. The y-axis represents systolic blood pressure (mm Hg), and the x-axis represents time post-dose (hours). The graph shows different trends for Sildenafil and placebo groups across the time period.*
FDA Label Image

Sildenafiltabletsfigture2 (Sildenafiltabletsfigture2)

Sildenafiltabletsfigture2 (Sildenafiltabletsfigture2)
A line graph illustrating the change in systolic blood pressure (SBP) over 8 hours post-dose. Two data series compare the effects of Doxazosin with Placebo and Doxazosin with Sildenafil 25 mg, showing changes in SBP (mmHg) on the y-axis and time post-dose in hours on the x-axis.*
FDA Label Image

Sildenafiltabletsfigture3 (Sildenafiltabletsfigture3)

Sildenafiltabletsfigture3 (Sildenafiltabletsfigture3)
A line graph showing change in systolic blood pressure (SBP) in mmHg over time (hours) after dosing. It compares two groups: subjects receiving Doxazosin with placebo and those receiving Doxazosin with Sildenafil 50 mg. The graph tracks SBP changes from 0 to 8 hours post dose, with the Doxazosin plus placebo group showing a slight increase and the Doxazosin plus Sildenafil group showing a decrease in SBP over time.*
FDA Label Image

Sildenafiltabletsfigture4 (Sildenafiltabletsfigture4)

Sildenafiltabletsfigture4 (Sildenafiltabletsfigture4)
A line chart showing the change in mmHg over time (hours) after dosing, comparing the effects of Doxazosin combined with Sildenafil 100 mg versus Doxazosin with placebo. The x-axis represents time after dosing from 0 to 8 hours, and the y-axis shows mmHg changes ranging from -50 to 40. Two data series are plotted, illustrating blood pressure changes over time for each treatment group.*
FDA Label Image

Sildenafiltabletsfigture5 (Sildenafiltabletsfigture5)

Sildenafiltabletsfigture5 (Sildenafiltabletsfigture5)
A line graph showing plasma concentration (ng/mL) over time (hours) post-dose, depicting the pharmacokinetic profile of Sildenafil oral tablets. The x-axis represents time from 0 to 24 hours, and the y-axis shows plasma concentration from 0 to 500 ng/mL, with a peak concentration occurring shortly after administration followed by a gradual decline.*
FDA Label Image

Sildenafiltabletsfigture6 (Sildenafiltabletsfigture6)

Sildenafiltabletsfigture6 (Sildenafiltabletsfigture6)
Two bar graphs illustrating the effect of Sildenafil tablets and placebo on maintenance of erection by baseline score. The top graph shows the percentage of patients at endpoint across baseline scores 0 to 5 for Sildenafil treatment, with higher percentages in score 5. The bottom graph shows similar data for placebo, with more variable percentages across scores.*
FDA Label Image

Sildenafiltabletsfigture7 (Sildenafiltabletsfigture7)

Sildenafiltabletsfigture7 (Sildenafiltabletsfigture7)
A vertical bar chart depicting the percentage of patients reporting improvement across four treatment groups: Placebo, Sildenafil Tablets 25 mg, 50 mg, and 100 mg. The chart shows increasing percentages from placebo to higher doses of Sildenafil, with the highest improvement at 100 mg.*
FDA Label Image
FDA Label Image

Sildenafiltablets25mgcontainerlabel (Sildenafiltablets25mgcontainerlabel)

Sildenafiltablets25mgcontainerlabel (Sildenafiltablets25mgcontainerlabel)
Label for Sildenafil Tablets, USP 25 mg film-coated tablets by Camber Pharmaceuticals, Inc. The label includes the NDC 31722-965-30, highlights the 25 mg strength, and indicates a package of 30 tablets. It provides storage instructions, contact information, and dosing reference to package insert.*
FDA Label Image

Sildenafiltablets50mgcontainetlabel (Sildenafiltablets50mgcontainetlabel)

Sildenafiltablets50mgcontainetlabel (Sildenafiltablets50mgcontainetlabel)
Sildenafil Tablets, USP 50 mg film-coated tablets label from Camber Pharmaceuticals, Inc. The carton contains 30 tablets for oral use. The label includes NDC 31722-966-30, dosage storage instructions, manufacturer contact information, and prescribing information reference. The label features the brand and dosage prominently in the center.*
FDA Label Image

Sildenafiltablets100mgcontainerlabel (Sildenafiltablets100mgcontainerlabel)

Sildenafiltablets100mgcontainerlabel (Sildenafiltablets100mgcontainerlabel)
This packaging label for Sildenafil Tablets, USP features a 100 mg strength in film-coated tablet form. It is labeled for oral use and includes a 30-tablet count. The label displays the Camber Pharmaceuticals, Inc. logo and provides storage instructions, dosage information, manufacturer and contact details, along with the NDC 31722-967-30.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.